Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS6309675 B1
Publication typeGrant
Application numberUS 09/358,223
Publication dateOct 30, 2001
Filing dateJul 21, 1999
Priority dateJul 21, 1999
Fee statusLapsed
Also published asUS6514540
Publication number09358223, 358223, US 6309675 B1, US 6309675B1, US-B1-6309675, US6309675 B1, US6309675B1
InventorsNancy Laning Sobczak
Original AssigneeNancy Laning Sobczak
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Therapeutic composition including plantain and aloe vera for treatment of arthritis and other afflictions
US 6309675 B1
Abstract
A therapeutic composition having plantain and aloe vera constituents is useful in the treatment of the symptoms of arthritis and other afflictions. The therapeutic composition may have only plantain and aloe vera constituents, wherein the plantain constituent is in a range of approximately 57% to 61% by weight of the therapeutic composition and the aloe vera constituent is in a range of approximately 39% to 43% by weight of the therapeutic composition. The therapeutic composition may have other constituents, such as herbal tinctures, added for various purposes, in which case, the plantain constituent is in a range of approximately 51% to 58% by weight of the therapeutic composition, the aloe vera constituent is in a range of approximately 37% to 39% by weight of the therapeutic composition, and the other constituent is in the range of approximately 5% to 10% by weight of the therapeutic composition.
Images(12)
Previous page
Next page
Claims(19)
I claim:
1. A therapeutic composition comprising:
a plantain constituent which is in a range of approximately 57% to 61% by weight of said therapeutic composition, said plantain constituent being comprised of a glycerin-based cream and an extract from a plantain plant (Plantago major), said glycerin-based cream being in a range of approximately 99 to 99.9% by weight of said plantain constituent, and said extract from said plantain plant being in a range of approximately 0.1 to 1.0% by weight of said plantain constituent, wherein said extract from said plantain plant acts as a medication to medicate tissue on an applicant below a skin barrier; and
an aloe vera constituent which is in a range of approximately 39% to 43% by weight of said therapeutic composition, said aloe vera constituent being comprised of a glycerin-based cream and an extract from an aloe vera plant (Aloe barbadensis), said glycerin-based cream being in a range of approximately 90 to 99.9% by weight of said aloe vera constituent, and said extract from said aloe vera plant being in a range of approximately 0.1 to 10.0% by weight of said aloe vera constituent, wherein said extract of said aloe vera plant acts as a vehicle to carry said extract from said plantain plant through the skin barrier of the applicant on which said therapeutic composition is topically applied in order to treat and relieve symptoms of any one of a group consisting of arthritis, hematomas, and infections in the tissue underlying the skin barrier.
2. The therapeutic composition of claim 1, wherein said plantain constituent and said aloe vera constituent are combined with an oral hygiene agent to be included in a toothpaste base to aid in good oral hygiene.
3. The therapeutic composition of claim 1, wherein said plantain constituent and said aloe vera constituent are combined with a saline solution of approximately 0.05% concentration for use as a nasal spray.
4. A therapeutic composition comprising:
a plantain constituent which is in a range of approximately 51% to 58% by weight of said therapeutic composition, said plantain constituent being comprised of a glycerin-based cream and an extract from a plantain plant (Plantago major), said glycerin-based cream being in a range of approximately 99 to 99.9% by weight of said plantain constituent, and said extract from said plantain plant being in a range of approximately 0.1 to 1.0% by weight of said plantain constituent, wherein said extract from said plantain plant acts as a medication to medicate tissue on an applicant below a skin barrier; and
an aloe vera constituent which is in a range of approximately 37% to 39% by weight of said therapeutic composition, said aloe vera constituent being comprised of a glycerin-based cream and an extract from an aloe vera plant (Aloe barbadensis), said glycerin-based cream being in a range of approximately 90 to 99.9% by weight of said aloe vera constituent, and said extract from said aloe vera plant being in a range of approximately 0.1 to 10.0% by weight of said aloe vera constituent, wherein said extract of said aloe vera plant acts as a vehicle to carry said extract from said plantain plant through the skin barrier of the applicant on which said therapeutic composition is topically applied in order to treat and relieve symptoms of any one of a group consisting of arthritis, hematomas, and infections in the tissue underlying the skin barrier; and
other herbal constituents of said therapeutic composition, wherein said other herbal constituents of said therapeutic composition is one or more of a group consisting of alfalfa leaf, dandelion root, licorice root, devil's claw, feverfew, chamomile, willow bark, any one of a group consisting of mullein leaf and tumeric, and any one of group consisting of yucca and burdock, said other herbal constituents of said therapeutic composition being in the range of approximately 5% to 10% by weight of said therapeutic composition, and wherein each of said other herbal constituents of said therapeutic composition ranges from approximately 0.1 to 1.0% by weight of said other herbal constituents.
5. A method of preparing a therapeutic composition for treating any one of a group consisting of arthritis, hematomas, and infections, said method comprising the steps of:
preparing a plantain constituent, said plantain constituent being made up of a glycerin-based cream and an extract from a plantain plant (Plantago major), said plantain constituent being in a range of approximately 57% to 61% by weight of said therapeutic composition, wherein a weight ratio of said glycerin-based cream is in a range of 90 to 99.9% by weight of said plantain constituent and said extract from said plantain plant is in a range of 0.1 to 10.0% by weight of said plantain constituent;
preparing an aloe vera constituent, said aloe vera constituent being made up of a glycerin-based cream and an extract from an aloe vera plant (Aloe barbadensis), said aloe vera constituent being in a range of approximately 39% to 43% by weight of a therapeutic composition, wherein a weight ratio of said glycerin-based cream in a range of 90 to 99.9% by weight of said aloe vera constituent and said extract from said aloe vera plant is in a range of 0.1 to 10.0% by weight of said aloe vera constituent; and
combining said plantain constituent and said aloe vera constituent to form said therapeutic composition for topical application to an applicant's skin at a site affected with any one of a group consisting of arthritis, hematomas, and infections, wherein said extract of said plantain plant acts as a medication to medicate tissue underlying a skin barrier of the applicant's skin and said extract of said aloe vera plant acts as a vehicle to carry said extract of said plantain plant through the skin barrier of the applicant's skin in order to treat the underlying tissue afflicted with any one of the group consisting of arthritis, hematomas, and infections.
6. The method of claim 5, wherein said preparing said plantain constituent includes the steps of:
thoroughly washing plantain leaves cut from said plantain plant;
any one of a group consisting of grinding and chopping said plantain leaves into a soft pulp;
placing said pulp in a container;
covering said pulp in said container with said glycerin-based cream to create a pulp and create mixture;
any one of a group consisting of cooling and refrigerating said pulp and cream mixture for approximately five to seven days;
putting said pulp and cream mixture through a sieve to create said plantain constituent said extract from said plantain plant; and
discarding said pulp sieved from said pulp and cream mixture.
7. The method of claim 5, wherein said preparing said aloe vera constituent includes the steps of:
cutting aloe vera leaves from said aloe vera plant;
slicing said aloe vera leaves into thick slices;
covering said thick slices of said aloe vera leaves with said glycerin-based cream to create a mixture of glycerin-based cream and thick slices of aloe vera leaves;
allowing said mixture of glycerin-based cream and thick slices of aloe vera leaves to stand in a warm area; and
straining said mixture of glycerin-based cream and thick slices of aloe vera leaves to yield said extract from said aloe vera plant in solution in said aloe vera constituent.
8. The method of claim 5, wherein said preparing said plantain constituent includes the steps of:
pressing leaves cut from said plantain plant to get said extract of said plantain plant; and
combining said extract from said plantain plant with said glycerin-based cream.
9. The method of claim 5, wherein said preparing said aloe vera constituent includes the steps of:
cutting aloe vera leaves from said aloe vera plant;
slicing said aloe vera leaves into thick slices;
covering said thick slices of said aloe vera leaves with glycerin to create a mixture of glycerin and thick slices of aloe vera leaves;
allowing said mixture of glycerin and thick slices of aloe vera leaves to stand in a warm area; and
straining said mixture of glycerin and thick slices of aloe vera leaves to yield said extract from said aloe vera plant in solution for combination with a commercially available, high viscosity cream.
10. The method of claim 9, wherein said combining of said plantain constituent and said aloe vera constituent includes combining a tincture of one or more of the group consisting of alfalfa leaf, dandelion root, licorice root, devil's claw, feverfew, chamomile, willow bark, mullein leaf, tumeric, yucca and burdock to form said therapeutic composition.
11. The method of claim 5, wherein said preparing said plantain constituent includes the steps of:
thoroughly washing plantain leaves cut from said plantain plant;
any on of a group consisting of grinding and chopping said plantain leaves into a soft pulp;
placing said pulp in a container;
covering said pulp in said container with said glycerin-based cream to create a pulp and cream mixture;
any one of a group consisting of cooling and refrigerating said pulp and cream mixture for approximately five to seven days;
putting said pulp and cream mixture through a sieve to create said plantain constituent containing said extract from said plantain plant; and
discarding said pulp sieved from said pulp and cream mixture.
12. A therapeutic composition produced by a process comprising the steps of:
preparing a plantain constituent of said therapeutic composition, wherein said plantain constituent of said therapeutic composition is made up of an extract from a plantain plant combined with a glycerin-based cream such that a weight ratio of said glycerin-based cream is in a range of 90 to 99.9% by weight of said plantain constituent of said therapeutic composition and said extract from said plantain plant is in a range of 0.1 to 10.0% by weight of said plantain constituent of said therapeutic composition, said plantain constituent of said therapeutic composition being in a range of approximately 57% to 61% by weight of said therapeutic composition;
preparing an aloe vera constituent of said therapeutic composition, wherein said aloe vera constituent of said therapeutic composition is made up of an extract from an aloe vera plant combined with a glycerin-based cream such that a weight ratio of glycerin-based cream is in a range of 90 to 99.9% by weight of said aloe vera constituent of said therapeutic composition and said extract from said aloe vera plant is in a range of 0.1 to 10.0% by weight of said aloe vera constituent of said therapeutic composition, said aloe vera constituent of said therapeutic composition being in a range of approximately 43% to 39% by weight of a therapeutic composition; and
combining said plantain constituent of said composition and said aloe vera constituent to form said therapeutic composition for topical application to an applicant's skin at a site affected with any one of a group consisting of arthritis, hematomas, skin rashes, and infections.
13. The therapeutic composition produced by the process of claim 12, wherein the step of preparing said plantain constituent of said therapeutic composition includes the steps of:
washing plantain leaves cut from said plantain plant thoroughly;
any one of a group consisting of grinding and chopping said plantain leaves into a soft pulp;
placing said soft pulp into a container;
covering said soft pulp in said container with any one of a group consisting of a glycerin-based cream and a high viscosity, commercially available cream to create a pulp and cream mixture;
any one of a group consisting of cooling and refrigeration said pulp and cream mixture for approximately five to seven days;
putting said pulp and cream mixture through a sieve to create said plantain constituent of said therapeutic composition containing said extract from said plantain plant; and
discarding said pulp sieved from said pulp and cream mixture.
14. The therapeutic composition produced by the process of claim 13, wherein the step of preparing said aloe vera constituent of said therapeutic composition includes the steps of:
cutting said aloe vera leaves from said aloe vera plant;
slicing said aloe vera leaves into thick slices;
covering said thick slices of said aloe vera leaves with a glycerin-based cream to create a mixture of glycerin-based cream and thick slices of aloe vera leaves;
allowing said mixture of glycerin-based cream and thick slices of aloe vera leaves to stand in a warm area; and
straining said mixture of glycerin-based cream and thick slices of aloe vera leaves to yield said extract of said aloe vera plant in solution in said aloe vera constituent of said therapeutic composition.
15. The therapeutic composition produced by the process of claim 14, wherein the step of combining said plantain constituent of said therapeutic composition and said aloe vera constituent of said therapeutic composition includes combining a tincture of a tincture of one or more of the group consisting of alfalfa leaf, dandelion root, licorice root, devil's claw, feverfew, chamomile, willow bark, mullein leaf, tumeric, yucca, and burdock to form said therapeutic composition.
16. The therapeutic composition produced by the process of claim 12, wherein the step of preparing said aloe vera constituent of said therapeutic composition includes the steps of:
cutting said aloe vera leaves from said aloe vera plant;
slicing said aloe vera leaves into thick slices;
covering said thick slices of said aloe vera leaves with a glycerin-based cream to create a mixture of glycerin-based cream and thick slices of aloe vera leaves;
allowing said mixture to glycerin-based cream and thick slices of aloe vera leaves to stand in a warm area; and
straining said mixture to glycerin-based cream and thick slices of aloe vera leaves to yield said extract of said aloe vera plant in solution in said aloe vera constituent of said therapeutic composition.
17. The therapeutic composition produced by the process of claim 12, wherein the step of preparing said plantain constituent of said therapeutic composition includes the steps of:
pressing leaves cut from said plantain plant to get said extract from said plantain plant; and
combining said extract from said plantain with a base solution from a group consisting of glycerin-based cream and a commercially available, high viscosity cream.
18. The therapeutic composition produced by the process of claim 12, wherein the step of preparing said aloe vera constituent of said therapeutic composition includes the steps of:
cutting aloe vera leaves from said aloe vera plant;
slicing said aloe vera leaves into thick slices;
covering said thick slices of said aloe vera leaves with liquid glycerin to create a mixture of glycerin and thick slices of aloe vera leaves;
allowing said mixture of glycerin and thick slices of aloe vera leaves to stand in a warm area; and
straining said mixture of glycerin and thick slices of aloe vera leaves to yield said extract from said aloe vera plant in solution in said liquid glycerin for combination with a cream to form said aloe vera constituent of said therapeutic composition.
19. The therapeutic composition produced by the process of claim 12, wherein the step of preparing said plantain constituent of said therapeutic composition includes the steps of:
washing plantain leaves cut from said plantain plant thoroughly;
any one of a group consisting of grinding and chopping said plantain leaves into a soft pulp;
placing said soft pulp into a container;
covering said soft pulp in said container with any of of a group consisting of glycerin-based cream and a high viscosity, commercially available cream to create a pulp and cream mixture;
any one of a group consisting of cooling and refrigerating said pulp and cream mixture for approximately five to seven days;
putting said pulp and cream mixture through a sieve to create said plantain constituent of said therapeutic composition containing said extract of said plantain plant; and
discarding a remnant weaved from said pulp and cream mixture.
Description
FIELD OF THE INVENTION

The present invention generally relates to compositions of matter and more particularly, to a therapeutic composition including plantain and aloe vera as its main ingredients in a particular percentage by weight arrangement with respect to each other in order for the therapeutic composition to be useful in the treatment and relief of the symptoms of arthritis and other afflictions.

BACKGROUND OF THE INVENTION

Plants and herbs have long been used for medicinal purposes. Indeed, native Americans have long known of the healing powers of certain herbs as remedies for various illnesses. However, much research still needs to be done in the area of herbal remedies and it is believed that present day healers have only begun to scratch the surface of the limitless possible cures offered by plants and herb.

One recent inroad into herbal cures came with the discovery that aloe vera may be used as a biological vehicle for the delivery of drugs. U.S. Pat. No. 5,708,038 (the '038 patent) discloses an embodiment wherein aloe vera is used as a biological vehicle to deliver the estrogen, β-estradiol and the androgen, testosterone propionate. The '038 patent also discloses a method of treating symptoms and diseases mediated by hormonal deficiencies or amenable to treatment by hormones using aloe vera as the biological vehicle for allowing penetration of drugs via a topical method.

Another example of using plants and herbs for medicinal purposes is disclosed in U.S. Pat. No. 5,192,542 which teaches that plantain may be used in a product for treating tissue to form closures of wounds, incisions, and other openings, particularly during the embalming process.

Other well known examples of using plants and herbs for medicinal purposes include: aspirin, which comes from the bark of a white willow tree; and digitalis, which comes from a flower commonly known as fox glove.

The present invention provides a therapeutic composition which combines the healing powers of plantain and aloe vera (also known simply as aloe) for use in the treatment of arthritis and other afflictions, such as hematomas, skin rashes and infections.

Arthritis is a disease characterized by an inflammation of the joints, such as the knees, wrists, elbows, fingers, toes, hips, shoulders, and neck and back (i.e., joints between the bones of the spine). The inflamation characteristic of arthritis is often accompanied by other symptoms such as mild to severe pain, swelling, weakness in associated areas, and deformity. Arthritic symptoms may come on gradually or appear suddenly. Some people feel sharp burning or grinding pain, while others compare the pain to a dull toothache. Movement of the joints is usually associated with pain, although sometimes there is only stiffness. In general, there is usually a pronounced weakness in the muscular strength in the affected area.

The onset of the disease of arthritis can be associated with physical or emotional stress, age, poor nutrition, age, and possibly bacterial infections or other maladies or dysfunctions of unknown origin.

Furthermore, other diseases of the highly vascular area of the head, including the mouth, throat, particularly, the teeth and tonsils, and the nose and sinuses, may play a role in the onset or intensification of the symptoms of arthritis.

Arthritis can manifest itself in many different forms. For instance, one common form of arthritis is osteoarthritis which is a degenerative joint disease related to the wear and tear or aging of the joint and involves deterioration of the smooth cartilage.

Other types of arthritis include rheumatoid and juvenile rheumatoid arthritis which can attack the synovial membranes surrounding the lubricating fluid in the joints. Often, the bone tissue and the cartilage and tissues in and around the joints are destroyed. The body replaces this damaged tissue with scar tissue which causes the spaces between the joints to become narrow in order to develop folds and to fuse together. The entire body is affected instead of just one joint as with other forms of arthritis. The disease creates stiffness, swelling, fatigue, anemia, weight loss, fever, and often crippling pain.

Another type of arthritis is ankylosing spondylitis (AS) which affects certain joints of the spine that become inflamed, stiffen, become rigid, and then, fuse together. If confined to the lower back, AS will cause virtually no limitation of movement. However, in some cases, the entire spine may become rigid and bent. If the joints between the ribs and spine are affected, severe breathing problems may result due to the limited expansion of the chest wall.

Another type of arthritis, systemic lupus erythematosus (SLE), involves a malfunction of the body's immune system. For reasons unknown, the body produces antibodies that act against itself. Although it mimics rheumatoid arthritis and results in painful and inflamed joints, SLE is not a crippling disease.

A therapeutic composition useful in the treatment of arthritis and other afflictions would be an important advance in managing the subject's symptoms.

It is an object of the present invention to provide a therapeutic composition of matter which combines the healing powers of plantain and aloe vera to treat arthritis and other afflictions.

SUMMARY OF THE INVENTION

The present invention relates to a therapeutic composition including: a plantain constituent which is in a range of approximately 57% to 61% by weight of the therapeutic composition; and an aloe vera constituent which is in a range of approximately 39% to 43% by weight of the therapeutic composition (in the case of topical applications).

The therapeutic composition may also include other constituents, such as any one or more of a group consisting of alfalfa leaf, dandelion root, licorice root, devils' claw, feverfew, chamomile, willow bark, either mullein leaf or tumeric, and either yucca or burdock. These other constituents are herbs that can be added to the main ingredients of the plantain and aloe vera for specific purposes, such as to act as an anti-inflammatory, a diuretic, a healing agent, or to act to remove poisons from the system, to reduce localized heat production, such as “hot spots,” or fever, etc. If the therapeutic composition contains other constituents, then the percentages of the plantain, aloe vera and other constituents are as follows: the plantain constituent is in a range of approximately 51% to 58% by weight of the therapeutic composition; the aloe vera constituent is in a range of approximately 37% to 39% by weight of the therapeutic composition; and the other constituents are in the range of approximately 5% to 10% by weight of the therapeutic composition (in the case of topical applications).

Regardless of whether the therapeutic composition includes other constituents, the plantain constituent may include a glycerin-based cream or lotion which is in a range of 99 to 99.9% by weight of the plantain constituent and a plantain extract which is in a range of 0.1 to 1.0% by weight of the plantain constituent. The aloe vera constituent may include a glycerin-based cream or lotion, which is in a range of 90 to 99.9% by weight of the aloe vera constituent, and an aloe vera extract, which is in a range of 0.1 to 10.0% by weight of the aloe vera constituent. Preferably, the aloe vera extract is derived from an Aloe barbadensis plant.

The plantain extract acts as a medication, while the aloe vera extract acts as a vehicle to carry the plantain extract through the skin barrier of a person on whom the therapeutic composition is topically applied in order to treat and relieve the symptoms of arthritis and/or other such treatable afflictions.

In another embodiment of the present invention, the plantain extract and aloe vera extract are contained in a joint compatible solution for injection directly into a joint (or a muscle near or surrounding the joint) of an applicant. The joint compatible solution may be a ringers-type solution or any other suitable isotonic substrate. In the case of injection directly into the joint, the plantain constituent would be in the range of approximately 0.01 to 0.1% by weight of the therapeutic composition and the aloe vera constituent would be in the range of approximately 0.01 to 1% by weight of the therapeutic composition (i.e., more diluted, since the therapeutic composition does not have to go through the skin and muscle layers as it does with a topical application).

In another embodiment of the present invention the plantain and aloe vera extracts are combined with any oral hygiene agent. The combination of plantain, aloe vera, and oral hygiene agent is then included in a toothpaste base for good oral hygiene and aiding in the cleansing of the mouth.

Finally, in another embodiment of the present invention, the plantain and aloe vera extracts are combined with a saline solution of approximately 0.05% concentration for use as a nasal spray.

DETAILED DESCRIPTION OF THE INVENTION

The present invention involves a composition of matter having plantain and aloe vera as its main ingredients. The composition of matter containing plantain and aloe vera is a therapeutic composition for use in the treatment and relief of the symptoms of arthritis, in particular, and other afflictions, such as, but not limited to, hematomas and skin rashes and infections. The plantain extract acts as a medication, while the aloe vera extract acts as a vehicle to carry the plantain extract through a skin barrier of an applicant on which the therapeutic composition is topically applied in order to treat and relieve symptoms of arthritis and other diseases.

The therapeutic composition of the present invention may include only a plantain constituent and an aloe vera constituent, in which case the plantain constituent is in a range of approximately 57% to 61% by weight of the therapeutic composition and the aloe vera constituent is in a range of approximately 39% to 43% by weight of the therapeutic composition.

The therapeutic composition may also include other constituents, such as any one of a single constituent and a plurality of constituents from a group consisting of alfalfa leaf, dandelion root, licorice root, devils' claw, feverfew, chamomile, willow bark, mullein leaf, tumeric, yucca and burdock. These other constituents are herbs that can be added to the main ingredients of the plantain and aloe vera to provide additional therapeutic efficacy or value.

More specifically, the plantain, aloe vera, and other possible ingredients (i.e., herbal tinctures or vitamins) of the therapeutic composition of the present invention are summarized in TABLE I below with respect to a description thereof, the active ingredients therein, and the benefits thereof.

TABLE I
DESCRIPTION ACTIVE INGREDIENTS BENEFIT
Aloe Vera Aloe vera is a perennial plant found wild in East and Carrisyn, salicylates, It is used to
South Africa. It is also cultivated in the West Indies and enzyme that inhibits conduct the active
other tropical areas. It has also been reported in the bradykinin (pain ingredient of the
Zapata area of Texas. It is also called barbados aloe transmitter), magnesium herbs through the
vera and curacao aloe vera. The strong, fibrous root lactate, compounds that skin barrier.
produces a rosette of fleshy basal leaves as in the agave, exhibit bacteriostatic and
but considerably smaller. The narrow-lanceolate leaves antifungal activity.
are 1 to 2 feet long and whitish-green on both sides, and
they bear spiny teeth on the margins.
Plantain Plantago major (Plantain) can be described as an annual, Vitamins C, D, E, and K It is used as a
biennial, or perennial herb with upwards of two- healing agent
hundred-seventy species. It produces rosettes of
glabrous or pubescent, ovate to elliptical leaves. It can
be described by the names, as follow: plantain rugelii,
English plantain (lanceolata), sand plantain
(patagonica), rattlesnake plantain (goodyera pubescen),
water plantain (alisma plantago aquatica), common
plantain, broad-leaved plantain, greater plantain, round-
leaved plantain, way bread, white man's foot, lance-leaf
plantain, buckhorn, chimney-sweeps, headsman,
ribgrass, ribwort, ripplegrass, snake plantain, and
solder's herb. Plantain is closely associated with the
activity of man. It is widely distributed throughout the
world, even at high elevations (2800 m in Valais,
Switzerland). It has a truly remarkable wide range of
distribution as it occurs from pole to pole, although
apparently absent from the lowland tropics. It is clearly
cosmopolitan. Plantain occurs in a very wide range of
soil types such as loarn, clay, and sand. It is a common
species of cultivated soil, waste ground, and roadsides.
The growing season in northern areas of the USA occurs
from mid-April to late October. Flowering can be
continuous over mid-June to October, with a peak in
July. Plantain is a long day plant and flowering fails
unless the photoperiod is greater than 13 hours. The
fruits mature 2 to 3 weeks after anthesis. Seeds are
always viable and germinate intermittently throughout
the growing season. Plantain is easily spread, since it is
wind pollinated and capable of full self-fertilization.
Alfalfa Alfalfa is a perennial plant found on the borders of Saponins, L-canaverine It is used as a
Leaf fields, in low valleys, and widely cultivated. The erect, (non-protein amino acid). diuretic and a
smooth stem grows from an elongated taproot to a height healing agent.
of 12 to 18 inches and bears pinnately trifoliate leaves
with oblong-obviate or linear-oblong leaflets. The blue
or purplish flowers grow in racemes from June to
August, producing finally the characteristic spirally
coiled seedpods.
Dandelion The dandelion is a perennial plant found almost Vitamins A and C It acts to remove
Root everywhere. The oblong or spatula, irregularly dentate poisons from the
or pinnatifid leaves, grow in a rosette from the milky body.
taproot, which also sends up one or more naked flower
stems, each terminating in a single yellow flower. The
familiar puffball that succeeds the flower is a globular
luster of achenes, each of which is fitted with a
parachute like tuft.
Licorice Licorice is a perennial plant found wild in southern and Glycosides, flavonoids, It acts as a diuretic
Root central Europe and parts of Asia, and cultivated asparagine, isoflavonoids, and a healing
elsewhere. The woody rootstock is wrinkled and brown chalcones and coumarins. agent. Since it is
on the outside, yellow on the inside, and tastes sweet. Glycyrrhetrinic acid (anti- high in Iron, it
The stem, which is round on the lower part and angular inflammatory), also enhances
higher up, bears alternate, odd-pinnate leaves with 3 to glycyrrhetrinic (anti- oxygenation of the
7 pairs of ovate, dark green leaflets. Axially racemes of viral). Others act as anti- body and acts as a
yellowish or purplish flowers appear from June to depressants and inhibit magnetic ion in
August, depending on location. enzymes that cause tooth the system.
decay.
Devil's The plant grows in the rugged Kalahari Dessert and is Harpogoside and Beta- Historically, it has
Claw named for the plant's elaborate thorny structure. sitosterol (anti- been used to treat
inflammatory properties). arthritis.
Feverfew Feverweed is a sticky and hairy, annual or perennial Sesquiterpene lactone, It is particularly
plant that grows in dry woods and thickets from Maine parthenolide (inhibits effective in
to Florida and west to Ontario, Minnesota, and production and secretion producing fever in
Missouri. The numerous stems are 1 to 4 feet high and of prostaglandis - the body.
bear opposite, fernlike leaves, 1 to 3 inches long, which substances released by
are pintail lobed and deeply serrated. The large, yellow, blood platelets and white
bell-shaped flowers grow in loose terminal racemes in blood cells which
August and September. contribute to
inflammation).
Chamomile There are two primary types of chamomile: Roman Essential oils, volatile oil It is used to
chamomile and German chamomile. It is a perennial bisabolol, flavonoid decrease
plant found in Hungary, the Czech Republic, Slovakia, apigenin (anti-anxiety and inflammation
Germany, Argentina, and Egypt. Roman (or English) useful in supporting alpha
chamomile is also available, but to a lesser extent in the bisabolol - an anti-
American market. It is a member of the daisy family inflammatory and anti-
and grows from four to twenty-four inches tall in spasmodic.
disturbed ground, commonly farmyards. If has firmly
cut leaves with flower petals in white rays and discs of
yellow and an ill-scented aroma.
Yucca Yucca root comes from the flowering yucca plant which Steroid-like saponins that It acts an anti-
is a member of the lily family that can grow to heights of elevate the body's inflammatory.
40 feet or more. production of cortisone.
Burdock Burdock is a biennial plant found in northern U.S. and High in minerals (good It is used to
Root in Europe, along fences, walls, and roadsides, in waste source of iron), good eliminate poisons
places, and around populated areas. The root is long, source of essential oils, in the system.
fleshy, gray-brown outside and whitish inside. In its compounds that exhibit
second year, the plant grows a furrowed, reddish, pithy bacteriostatic and anti-
stem with wooly branches. During the first year, fungal activity.
burdock has only basal leaves. Both basal and stem
leaves are oblong-cordate to cordate, green and hairy on
top and downy gray beneath. The purple flowers appear
in loose corymbose clusters from July to September.
Willow White willow is a deciduous tree found in moist places Aspirin (acetylsalicylic It acts as an anti-
Bark in North Africa, central Asia, and in Europe, from where acid). inflammatory and
it was introduced into the northeastern U.S. Covered as a healing agent.
with rough, gray bark, the tree grows up to 65 feet high.
in some parts of the world, it is also grow as a shrub. Its
alternate, lanceolate, serrate leaves are ashy-gray in
color and silky on both sides. Made and female flowers
occur on separate trees and appear in catkins on leafy
stalks at the same time as the leaves
Mullein Essential flavoring spice of indian and other cuisine. Curcumin (increases
Leaf OR Tumeric rhizome provides the typical yellow coloring of secretion of bile, protects
Tumeric many curry dishes. liver by detoxification,
stimulates gall bladder
and scavenges free
radicals, inhibits platelet
aggregation and the
enzymes which induce
inflammatory
prostaglandins) and
essential oils (tumerone,
zingiberins)
Vitimin A Vitamin A Helps build
strong, healthy
bones/joints.
Vitamin C Vitamin C Helps build
strong, healthy
bones/joints.
Vitamin D Vitamin D Helps build
strong, healthy
bones/joints.
Vitamin E Vitamin E Anti-oxident.
Panthenol Vitamin B15 Anti-oxident and
(Vitamin aids in protein
B15) synthesis, which
action is improved
if taken with
vitamins A and E.

If the therapeutic composition contains other constituents, then the percentages of the plantain, aloe vera, and other constituents are as follows: the plantain constituent is in a range of approximately 51% to 58% by weight of the therapeutic composition; the aloe vera constituent is in a range of approximately 37% to 39% by weight of the therapeutic composition; and the other constituents are in the range of approximately 5% to 10% by weight of the therapeutic composition.

Regardless of whether the therapeutic composition includes other constituents or not, one embodiment of the present invention has, as follows: the plantain constituent being a mixture of a glycerin-based cream or lotion and a plantain extract, in which case the glycerin-based cream or lotion is in a range of 99 to 99.9% by weight of the plantain constituent and the plantain extract is in a range of 0.1 to 1.0% by weight of the plantain constituent; and the aloe vera constituent being a mixture of a glycerin-based cream or lotion and aloe vera extract, in which case the glycerin-based cream or lotion is in a range of 90 to 99.9% by weight of the aloe vera constituent and the aloe vera extract is in a range of 0.1 to 10.0% by weight of the aloe vera constituent.

It should be noted that the aloe vera extract is derived from an Aloe barbadensis plant. Aloe vera or aloe may also be referred to by any of its many botanical names such as, Aloe latifolia, Aloe perryi, Aloe saponaria, and Aloe tenuior. Furthermore, aloe vera or aloe has numerous common names such as, Bombay aloe, Barados aloe, and Curacao aloe.

Numerous trials were performed in which the optimum percentages of the plantain, aloe vera, and herbs, if any, were discovered.

Tables II and III (below) show data from a first trial (hereinafter Trial One), wherein: in a first step, the aloe vera and plantain constituents are manufactured; the plantain constituent (i.e., plantain extract and glycerin-based cream or lotion) had an estimated weight of 80 grams; and the aloe vera constituent (i.e., aloe vera extract and glycerin-based cream or lotion) had an estimated weight of 60 grams.

In other words, Trial One (Tables II and III) need to be viewed as a two step process. In Step One (a), an aloe vera extract and constituent are processed, and in Step One (b), a plantain constituent is processed. Please note these are two independent processes. In Step Two, the aloe vera extract and constituent and the plantain constituent are mixed with other tinctures. The mixing process occurs using the constituents of Step One.

In the case of Trial One, Step One, there were no other constituents. Thus, with respect to Trial One, Step One, where the plantain constituent and the aloe vera constituent were the only two constituents of the therapeutic composition and no other constituents were added, the therapeutic composition had a total estimated weight of 140 grams so that the percentage of the plantain constituent was 80/140 or approximately 57% and the percentage of the aloe vera constituent was 60/140 or approximately 43%.

TABLE II
Trial One, Step One
Estimated Weights and Percentages of Added Active Ingredients
Estimated Low Range High Range Low Range High Range
Weights Constituent Percentage Raw Herb Raw Herb Total Herb Total Herb
Plantain Extract 80 grams 80/140 = 0.5714285 0.1% 1.0% 0.0571% 0.5714%
and
Cream/Lotion
Aloe Vera 60 grams 60/140 = 0.4285714 0.1% 10.0% 0.0428% 4.2857%
Extract and
Cream/Lotion
TOTAL 140 grams  0.2% 11.0% 0.0999% 4.8571%

Table III (below) shows data from the second step of trial one (hereinafter Trial One, Step Two), wherein: the plantain constituent (i.e., plantain extract and glycerin-based cream or lotion) had an estimated weight of 80 grams; the aloe vera constituent (i.e., aloe vera extract and glycerin-based cream or lotion) had an estimated weight of 60 grams; and the other constituents had a combined estimated weight of 15 grams. Thus, if the therapeutic composition contained the plantain constituent, the aloe vera constituent, and other constituents, then the therapeutic composition had a total estimated weight of 155 grams so that the percentage of the plantain constituent was 80/155 or approximately 51%, the percentage of the aloe vera constituent was 60/155 or approximately 39%, and the percentage of other constituents was 15/155 or approximately 10%.

TABLE III
Trial One, Step Two
Estimated Weights and Percentages of Added Active Ingredients
Estimated Constituent Low Range High Range Low Range High Range
Weights Percentage Raw Herb Raw Herb Total Herb Total Herb
Plantain Extract 80 gms 80/155 = 0.516129 0.1% 1.0% 0.0516% 0.5161%
and Cream/Lotion
Aloe Vera Extract 60 gms 60/155 = 0.3870967 0.1% 10.0% 0.3871% 3.8710%
and Cream/Lotion
Herbal Tinctures 15 gms 15/155 = 0.0967741
Alfalfa 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Leaf
Dandelion 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Root
Licorice 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Root
Devil's 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Claw
Feverfew 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Chamomile 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Yucca/ 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Burdock
Willow 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Bark
Mullein 1.6667 gms 0.1% 1.0% 0.0011% 0.0108%
Leaf
TOTAL 155 grams 2.0% 20.0% 0.04484% 4.4839%

Tables IV and V (below) show data from a second trial (hereinafter Trial Two), wherein: in a first step, the aloe vera and plantain constituents are manufactured; the plantain constituent (i.e., plantain extract and glycerin-based cream or lotion) had an estimated weight of 310 grams; and the aloe vera constituent (i.e., aloe vera extract and glycerin-based cream or lotion) had an estimated weight of 195 grams. In the case of the Trial Two, Step One, there were no other constituents. Thus, with respect to Trial Two, Step One, where the plantain constituent and the aloe vera constituent were the only two constituents of the therapeutic composition and no other constituents were added, the therapeutic composition had a total estimated weight of 505 grams so that the percentage of the plantain constituent was 310/505 or approximately 51% and the percentage of the aloe vera constituent was 195/505 or approximately 39%.

TABLE IV
Trial Two, Step One
Estimated Weights and Percentages of Added Active Ingredients
Estimated Low Range High Range Low Range High Range
Weights Constituent Percentage Raw Herb Raw Herb Total Herb Total Herb
Plantain Extract 310 grams 310/505 = 0.6138613 0.1% 1.0% 0.0614% 0.6138%
and Cream/Lotion
Aloe Vera Extract 195 grams 195/505 = 0.3861386 0.1% 10.0% 0.0386% 3.8613%
and Cream/Lotion
TOTAL 505 grams 0.2% 11.0% 0.100% 4.4751%

Table V (below) shows data from a second step of the second trial (hereinafter Trial Two, Step Two), wherein: the plantain constituent (i.e., plantain extract and glycerin-based cream or lotion) had an estimated weight of 310 grams; the aloe vera constituent (i.e., aloe vera extract and glycerin-based cream or lotion) had an estimated weight of 195 grams; and the other constituents had a combined estimated weight of 25 grams. Thus, if the therapeutic composition contained the plantain constituent, the aloe vera constituent, and other constituents, then the therapeutic composition had a total estimated weight of 530 grams so that the percentage of the plantain constituent was 310/530 or approximately 58%, the percentage of the aloe vera constituent was 195/530 or approximately 37%, and the percentage of other constituents was 25/530 or approximately 5%.

TABLE V
Trial Two, Step Two
Estimated Weights and Percentages of Added Active Ingredients
Estimated Constituent Low Range High Range Low Range High Range
Weights Percentage Raw Herb Raw Herb Total Herb Total Herb
Plantain Extract 310 grams 310/530 = 0.5849056 0.1% 1.0% 0.0585% 0.5849%
and Cream/Lotion
Aloe Vera Extract 195 gms 195/530 = 0.3679245 0.1% 10.0% 0.0368% 0.5849%
and Cream/Lotion
Herbal Tinctures 25 gms  25/530 = 0.0471698
Alfalfa Leaf 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Dandelion 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Root
Licorice 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Root
Devil's 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Claw
Feverfew 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Chamomile 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Yucca/ 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Burdock
Willow 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Bark
Mullein 2.7778 gms 0.1% 1.0% 0.0005% 0.0052%
Leaf
TOTAL 530 grams 2.0% 20.0% 0.0999% 4.3109%

Table VI shows the low range averages and the high range averages between Trial One, Step One and Trial Two, Step One, wherein there were no other constituents (i.e., only plantain and aloe vera constituents).

TABLE VI
Herb Low/High Range Averages from Trial One,
Step One and Trial Two, Step One
Constituent Percentage from Low High
Trial One, Step One to Trial Range Range
Two, Step one Average Average
Plantain Extract from 80/140 = 0.5714285 0.0592% 0.5926%
and Cream/Lotion to 310/505 = 0.6138613
Aloe Vera Extract from 60/140 = 0.4285714 0.0407% 4.0735%
and Cream/Lotion to 195/505 = 0.3861386
TOTAL 0.0999% 4.6661%

Table VII shows the low range averages and the high range averages between Trial One, Step Two and Trial Two, Step Two, wherein there were other constituents in addition to the plantain and aloe vera constituents.

TABLE VII
Herb Low/High Range Averages from Trial One, Step Two and Trial
Two, Step Two
Low Range High Range
Constituent Percentage Average Average
Plantain Extract from 80/155 = 0.516129 0.0551% 0.5505%
and Cream/Lotion to 310/530 = 0.5849056
Aloe Vera Extract from 60/155 = 0.0377% 3.7751%
and Cream/Lotion 0.3870967 to
195/530 = 0.3679245
Herbal Tinctures from 15/155 =
0.0967741 to
25/530 = 0.0471698
Alfalfa 0.0008% 0.0080%
Leaf
Dandelion 0.0008% 0.0080%
Root
Licorice 0.0008% 0.0080%
Root
Devil's 0.0008% 0.0080%
Claw
Feverfew 0.0008% 0.0080%
Chamomile 0.0008% 0.0080%
Yucca/ 0.0008% 0.0080%
Burdock
Willow 0.0008% 0.0080%
Bark
Mullein 0.0008% 0.0080%
Leaf
TOTAL 0.4398% 4.3976%

The method of preparation of aloe vera extract, plantain extract, and herbal tinctures will now be described.

For extraction of aloe vera, the leaves are cut from an aloe vera plant and sliced into thick slices. The thick slices of the aloe vera plant are then covered with glycerin and allowed to stand in a warm area. The mixture of the thick slices from the aloe vera plant covered with glycerin is then strained to yield the aloe vera extract in a solution that can be combined with a cream or lotion to be applied topically. Then, the cream or lotion, glycerin and aloe vera extract mixture can be enhanced by the addition of vitamin A, vitamin D, vitamin E, and panthenol or else any commercially available lotion containing aloe vera, vitamin A, vitamin D, vitamin E, and panthenol can be used. The vitamins, if added, have the benefit of nuturing the bones and joints and some of the vitamins may function as an anti-oxident to aid in overall health.

For extraction of plantain, the plantain leaves are harvested and thoroughly washed and rinsed. After the plantain leaves are washed and rinsed, they are ground or chopped to create a soft pulp. The pulp is placed in a container and covered with either glycerin or a high viscosity, commercially available hand cream or lotion. The container is then placed in a refrigerator or otherwise cooled for a period of time (approximately five (5) to seven (7) days). Then, the pulp and lotion mixture is put through a sieve to create a solution that contains the plantain extract or juice and leaving the pulp from the plantain leaves to be discarded. Alternatively, the extract or juice of the plantain leaves may be extracted directly by pressing the leaves. Then, extract or juice pressed from the plantain leaves is combined with a base solution, such as glycerin or a commercially available high viscosity cream or lotion.

Herbal tinctures may be purchased commercially (i.e., already prepared) or may be prepared by using either a hot or cold infusion technique, with vegetable oil, glycerin, mineral oil, or some other agent as the basic solution. The tinctures of each individual herb should be made separately and then combined with the plantain and aloe vera mixture to create the therapeutic composition.

Clinical trials on the therapeutic composition of matter of the present invention which includes a mixture of medicinal plants, such as plantain and aloe vera, with or without herbal tinctures. The clinical trials have shown that the therapeutic composition is useful in the treatment and relief of arthritic symptoms and the eradication of disease, affecting cures of clinical symptoms in acute cases, and achieving considerable improvement in chronic cases. The therapeutic composition of the present invention was applied topically on the affected site (usually, a joint) during the clinical trials until the desired results are achieved.

The therapeutic composition of matter of the present invention which includes a mixture of medicinal plants, such as plantain and aloe vera, and which does not include any herbal tinctures, has also been found useful in the treatment and relief of hematoma (particularly, to the ocular region), affecting cures of clinical symptoms in less than seven (7) days and often in as little as three or four days. The therapeutic composition of matter of the present invention should be applied topically to the affected site (i.e., area around the eye, if the hematoma is in the ocular region) until the desired results are achieved. It should be noted that for hematomas in the ocular region, the therapeutic composition of matter needs to be applied a minimum of seven times a day, whereas hematomas in other areas of the body do not need application as often.

The therapeutic composition of matter of the present invention which includes a mixture of medicinal plants, such as plantain and aloe vera, and which does not include any herbal tinctures, has also been found useful in the treatment of skin infections, affecting cures of clinical symptoms in as little as a single application. As above, the therapeutic composition should be applied topically to the affected area of skin until the desired results are achieved.

Clinical trials, which have been performed using the therapeutic composition containing at least a plantain constituent and an aloe vera constituent in a cream or lotion form applied topically and found to be helpful in the treatment and relief of the symptoms of arthritis and other afflictions, will now be described.

EXAMPLE 1

An 89-year-old female (hereinafter Subject No. 1) had an inflamed joint of the middle finger of the right hand. The joint exhibited inflammation, pain, and swelling, and was warm to the touch. In addition, the entire finger and part of the hand was affected by the pain and the swelling resulting in restricted use of the hand.

Subject No. 1 received conventional treatment of steroids. The steroids were both injected locally and ingested in the form of up to 80 mg of prednazone, which was taken orally over a period of four to five months. In both cases of the local injection and ingestion of steroids, there was some initial success in relieving both the pain and swelling, but upon elimination of the drug, the symptoms returned.

Subject No. 1 was prescribed a cream or lotion form of the therapeutic composition of the present invention and the cream or lotion was applied to the finger and hand resulting in immediate relief of the pain upon application. Approximately 2 to 3 hours after application of the cream or lotion, the pain returned, but at a somewhat diminished level. Subsequent applications of the cream or lotion with intermittent applications of dry heat resulted in relief of the symptoms in approximately three weeks and a return to normal dexterity and mobility. During this period, the frequency of the application of the cream or lotion and heat gradually diminished to three times per day without a need for augmentation of the treatment with heat.

Subject No. 1 has been treated for subsequent reoccurrences in a similar manner resulting in control of the symptoms described.

EXAMPLE 2

A 46-year-old female (hereinafter Subject No. 2) had arthritis symptoms in the wrist, knees, toes, and fingers. Onset of these symptoms can result in a two- to three-fold increase in the size of a joint, with an inflammation of the surrounding tissue. This can occur in a matter of hours and affects the associated limb resulting in substantial pain, a loss of strength in the entire limb, sleep interruption (due to pain), and general malaise due to the intensity and continuous nature of the throbbing.

In the case of Subject No. 2's toes, fingers and wrists, a cream or lotion form of the therapeutic composition of the present invention was applied topically to the affected area and augmented by the application of dry heat, such as from a heat lamp. Within two weeks, the heat applications were no longer needed and the pain and swelling had diminished greatly. Subsequent applications of the cream or lotion resulted in even further relief of the symptoms, although the results were not as dramatic. Strength was returned to the limbs.

In the case of Subject No. 2's knees, application of a cream or lotion form of the therapeutic composition of the present invention to the knee joint resulted in an increased swelling around the knee with some diminishing of the pain in the joint area. It appeared that beneath the skin, there was a poultice effect that caused the creation of a local immune response resulting in a large “pimple” under the skin. After approximately one week of treatment, the “pimple” broke sending its contents into the lower extremity of the leg. This resulted in what appeared to be a chemical imbalance causing a muscle cramp due to the increase of fluid and what is surmised to be toxins or electrolyte imbalance. Once the system eliminated this waste material, the entire limb was returned to a normal state. Strength in the limbs and joints was returned and the knee joint returned to its normal size which Subject No. 2 reported was the first time in twelve years. The knee was the only joint to exhibit this radical response and healing scenario. It is believed to be a result of the large surface area exposure that the knee offers to the topically applied treatment as compared with the relatively small surface area exposures of a toe or a finger.

In the case of Subject No. 2's wrists, one wrist had been injured due to a fall which was sustained during the course of treatment. This resulted in a rapid return of the previous symptoms, such as pain, weakness of the entire limb, and slightly increased swelling. After application of a cream or lotion form of the therapeutic composition of the present invention, these symptoms were eliminated within a fourteen-hour period. It is believed that there was a rupture or leakage of the fluid around the joint, which resulted in the symptoms and also presented the cream or lotion with the opportunity to work quickly to alleviate symptoms due to the increase surface area presented under the circumstances.

Subject No. 2 is now relatively free of pain and continues to use the cream or lotion to alleviate any remaining or subsequent symptoms that arise from time to time.

EXAMPLE 3

A 76-year-old female (hereinafter Subject No. 3) was on a blood thinner medication and had fallen in a handicap van on her way to physical therapy. The fall resulted in a black eye to the left side of the head. A cream or lotion form of the therapeutic composition of the present invention was applied four times a day to the affected area and resulted in the elimination of the symptoms in five days. After only three days, the bruise was visible only upon close examination and appeared to be yellowish orange in color.

EXAMPLE 4

A 48-year-old male (hereinafter Subject No. 4) had an infected hair follicle on the right side of his neck, which resulted in an inflamed and sensitive area of a size approximately one-half inch in diameter. Subject No. 4 had first attempted to eliminate the symptoms by applying an aloe vera cream or lotion and this attempt proved unsuccessful. A cream or lotion form of the therapeutic composition of the present invention was prescribed and applied to the affected area in the late afternoon. By the next morning, symptoms were eliminated and no subsequent applications were required.

EXAMPLE 5

An 83-year-old male (hereinafter Subject No. 5) complained of an insect bite of unknown origin. The area surrounding the bite was red and slightly swollen. The total diameter of the affected area was approximately two inches. The center of the affected area contained an obvious point of entry of the insect's stinger and was cherry-red in color. The remaining reddened area around the point of entry was clearly a direct result of the insect bite. Subject No. 5 had applied a cortisone-based over the counter remedy and reported no relief of the symptoms. After one application of a cream or lotion form of the therapeutic composition of the present invention, the complained-of symptoms were eliminated.

There are a number of key substances in the therapeutic composition which contribute to is effectiveness in treatment and relief of the symptoms of arthritis and other afflictions. The aloe vera provides a means of conducting the vitamins, herbal infusions, and tinctures through the skin to the affected area. The plantain and other herbs, which normally are taken internally, now have an opportunity to pass through the skin barrier into the affected area after topical application of the therapeutic composition of the present invention. In acute, active arthritis sites, it is the synovial membranes, and not the bone itself, that are attacked. Thus, the remedy, in most cases, has a small internal area to traverse before reaching the target site.

While it cannot repair previously deformed joints, it is believed that the curative powers of the herbs, particularly plantain, can then work on the affected joint area to alleviate the symptoms of a specified affected site. Since it is believed that the root cause of this disease is not a function of the swelling of any particular joint, it can only affect the site at which it is applied. However, the systematic elimination of the painful symptoms of each affected site will give the body the opportunity to focus its immune system response on other areas, thereby, hopefully, eliminating the root cause.

The healing process is aided by the ingestion of oral herbal medications of the same herbs used in the cream or lotion, as well as good nutrition and exercise. Exercise is very crucial in the healing process, since it has been shown that distributing the fluid surrounding the affected joint can result in a dispersion of the joint fluid resulting in a greater surface which therefore presents a greater opportunity for the cream or lotion to effectively eliminate the symptoms.

In another embodiment of the present invention, the plantain extract and aloe vera extract are contained in a joint compatible solution for injection directly into a joint (or a muscle near or surrounding the joint) of an applicant. The joint compatible solution may be a ringers-type solution or any other isotonic substrate. In the case of injection directly into the joint, the plantain constituent would be in the range of approximately 0.01 to 0.1% by weight of the therapeutic composition and the aloe vera constituent would be in the range of approximately 0.01 to 1% by weight of the therapeutic composition (i.e., more diluted, since the therapeutic composition does not have to go through the skin and muscle layers as it does with a topical application).

The therapeutic composition of the present invention may also take a form where the plantain and aloe vera extracts are combined with an oral hygiene agent. Then, the combination of plantain, aloe vera, and oral hygiene agent is included in a toothpaste base to aid in good oral hygiene.

Finally, the therapeutic composition of the present invention may have the plantain extract and aloe vera extract combined with a saline solution of approximately 0.05% concentration for use as a nasal spray.

The form of the invention described in the present disclosure represents only an illustrative embodiment thereof. It is to be understood that various changes may be made without departing from the teachings of the invention defined by the claimed subject matter which follows.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US5011689Dec 11, 1989Apr 30, 1991T. Paul MisenkoComposition of matter and method for treating poison ivy
US5192542Feb 2, 1990Mar 9, 1993Hubbs James JTissue sealant product and method
US5204103Aug 29, 1991Apr 20, 1993Pharmalett International B.V.Use of polysaccharides in preparation for wound treatment
US5578312 *Dec 15, 1994Nov 26, 1996Parrinello; Vincene M.Skin care system and method for improving moisture retention in skin
US5708038Jun 13, 1996Jan 13, 1998Univera Pharmaceuticals, Inc.Method of using aloe vera as a biological vehicle
US5738850 *May 17, 1995Apr 14, 1998Hendricks; Horst WalterTherapeutic composition for the treatment of skin lesions and methods for its preparation
US5843467 *Jul 15, 1996Dec 1, 1998Ambroziewigz; WieslawTopical ointment consisting of animal fat, plantain lancetowata, and calendula and methods of producing the same
US5882666 *Nov 20, 1997Mar 16, 1999Averill; Robert G.Skin care compounds and preparation thereof
EP0636373A1 *Jul 19, 1994Feb 1, 1995Inkeysa, S.A.Compositions comprising Plantago Mayor, Rosa Canina and Citrus Aurantium for treating psoriasis
HU33033A * Title not available
HU50623A * Title not available
RU2121341C1 * Title not available
Non-Patent Citations
Reference
1 *Pierce, A. Am. Pharm. Assoc.-Practical Guide to Natural Medicines, pp. 31-35, 1998.
2Pierce, A. Am. Pharm. Assoc.—Practical Guide to Natural Medicines, pp. 31-35, 1998.
3Tyler, V. Herbs of Choice. Haworth Press, Inc. Birmingham, NY, pp. 92-93 and 155-157, 1994.*
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6485711Mar 21, 2002Nov 26, 2002Michael J. OlmsteadOrganic toothpaste containing saponin
US6506387 *Apr 20, 1999Jan 14, 2003Paxa N.V.Method for preparing aloin by extraction
US6777000Feb 28, 2001Aug 17, 2004Carrington Laboratories, Inc.In-situ gel formation of pectin
US7485110Jun 27, 2003Feb 3, 2009Kimberly Clark Worldwide, Inc.Wipe comprising a pathogen selective antimicrobial
US7691986Apr 23, 2003Apr 6, 2010Nanotherapeutics, Inc.High molecular weight, low methoxyl pectins, and their production and uses
US7705135May 19, 2006Apr 27, 2010Nanotherapeutics, Inc.Pharmaceutical compositions comprising aloe pectins, and methods for their production and use
US8216615Mar 1, 2007Jul 10, 2012Phoenix Eagle Company Pty. Ltd.Pawpaw and peach derived composition
US8685473Jun 8, 2012Apr 1, 2014Phoenix Eagle Company Pty. Ltd.Pawpaw and/or peach derived composition
US9579357Aug 22, 2016Feb 28, 2017Anc Products, LlcTherapeutic compositions
US20040039353 *Jun 27, 2003Feb 26, 2004Kimberly-Clark Worldwide, Inc.Wipe comprising a pathogen selective antimicrobial
US20050106215 *Dec 10, 2002May 19, 2005Elizabeth Offord-CavinFood or pet food composition containing plant extract for bone health
US20050137541 *Feb 10, 2005Jun 23, 2005Kimberly-Clark Worldwide, Inc.Methods of inhibiting the production of ammonia from urine
US20060024385 *Jul 27, 2004Feb 2, 2006Pedersen Mark AMetabolic capacity enhancing compositions and methods for use in a mammal
US20060105059 *Jul 22, 2003May 18, 2006Phoenix Eagle Company Pty Ltd.Fruit and/or vegetable derived composition
US20060105063 *Nov 17, 2005May 18, 2006Kent HannSynergic combination of compositions containing aloe vera isolates and their therapeutic application
US20070048386 *Aug 30, 2006Mar 1, 2007Mallozzi Ottavio SrMedicament for treating inflammatory and non-inflammatory arthritis
CN1319981C *Jul 19, 2002Jun 6, 2007郭绪林Preparation process of plantago fotal glycocide and its application in medicine
Classifications
U.S. Classification424/738, 514/865, 514/886, 514/861, 514/864, 514/825, 514/863, 424/744, 514/862
International ClassificationA61K36/886, A61K36/68
Cooperative ClassificationY10S514/862, Y10S514/886, Y10S514/825, Y10S514/861, Y10S514/864, Y10S514/865, Y10S514/863, A61K36/886, A61K36/68
European ClassificationA61K36/886, A61K36/68
Legal Events
DateCodeEventDescription
Oct 31, 2005REINReinstatement after maintenance fee payment confirmed
Dec 27, 2005FPExpired due to failure to pay maintenance fee
Effective date: 20051030
Jan 4, 2006SULPSurcharge for late payment
Jan 4, 2006FPAYFee payment
Year of fee payment: 4
Sep 4, 2006PRDPPatent reinstated due to the acceptance of a late maintenance fee
Effective date: 20060905
Nov 17, 2008FPAYFee payment
Year of fee payment: 8
Jun 7, 2013REMIMaintenance fee reminder mailed
Oct 30, 2013LAPSLapse for failure to pay maintenance fees
Dec 17, 2013FPExpired due to failure to pay maintenance fee
Effective date: 20131030